Neoadjuvant therapy and liver transplantation for hilar cholangiocarcinoma: Is pretreatment pathological confirmation of diagnosis necessary?

Journal of the American College of Surgeons

Volumn 215, Issue 1, 2012, Pages 31-38

  Rosen, Charles B ^a   Darwish Murad, Sarwa ^a   Heimbach, Julie K ^a   Nyberg, Scott L ^a   Nagorney, David M ^a   Gores, Gregory J ^a  

^a MAYO CLINIC ROCHESTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL;

ARTICLE; BILE DUCT CARCINOMA; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; EXTERNAL BEAM RADIOTHERAPY; FEMALE; HUMAN; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CHOLANGIOCARCINOMA; HUMANS; LIVER TRANSPLANTATION; NEOADJUVANT THERAPY; PREOPERATIVE CARE; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 84862981935     PISSN: 10727515     EISSN: 18791190     Source Type: Journal    
DOI: 10.1016/j.jamcollsurg.2012.03.014     Document Type: Article

References (25)

1. Rea DJ, Munoz-Juarez M, Farnell MB, et al. Major hepatic resection for hilar cholangiocarcinoma: analysis of 46 patients. Arch Surg 1996;224:628-639.
2. Pichlmayr R, Weimann A, Klempnauer J, el al. Surgical treatment in proximal bile duct cancer. A single-center experience. Ann Surg 1996;224:628-638. (Pubitemid 26384886)
3. Jang JY, Kim SW, Park DJ, et al. Actual long-term outcome of extrahepatic bile duct cancer after surgical resection. Ann Surg 2005;241:77-84. (Pubitemid 40040995)
4. Jarnagin WR, Fong Y, DeMatteo RP, et al. Staging, respectability, and outcome in 225 patients with hilar cholangiocarcinoma. Ann Surg 2001;234:507-517.
5. Washburn WK, Lewis WD, Jenkins RL. Aggressive surgical resection for cholangiocarcinoma. Arch Surg 1995;130:270-276.
6. Rosen CB, Nagorney DM, Wiesner RH, et al. Cholangiocarcinoma complicating primary sclerosing cholangitis. Ann Surg 1991;213:21-25.
7. Meyer CG, Penn I, James L. Liver transplantation for cholangiocarcinoma: results in 207 patients. Transplantation 2000;69: 1633-1637.
8. Robles R, Figueras J, Turrion VS, et al. Spanish experience in liver transplantation for hilar and Peripherals cholangiocarcinoma. Ann Surg 2004;239:265-271. (Pubitemid 38176362)
9. Brandsaeter B, Isoniemi H, Broome U, et al. Liver transplantation for primary sclerosing cholangitis; predictors and consequences of hepatobiliary malignancy. J Hepatol 2004;40:815-822. (Pubitemid 38507363)
10. Ghali P, Marotta PJ, Yoshida EM, et al. Liver transplantation for incidental cholangiocarcinoma: analysis of the Canadian experience. Liver Transpl 2005;11:1412-1416. (Pubitemid 43071591)
11. Sudan D, DeRoover A, Chinnakotla S, et al. Radiochemotherapy and transplantation allow long-term survival for nonresectable hilar cholangiocarcinoma. Am J Transplant 2002; 2:774-779. (Pubitemid 36342621)
12. De Vreede I, Steers JL, Burch PA, et al. Prolonged disease-free survival after orthotopic liver transplantation plus neoadjuvant chemoirradiation for cholangiocarcinoma. Liver Transpl 2000; 6:309-316. (Pubitemid 30317226)
13. Gores GJ, Gish RG, Sudan D, Rosen CB, the MELD Exception Study Group. Model for end-stage liver disease (MELD) exception for cholangiocarcinoma or biliary dysplasia. Liver Transplant 2006;12[Suppl 3]:S95-S97. (Pubitemid 44911780)
14. De Bellis M, Sherman S, Fogel EL, et al. Tissue sampling at ERCP in suspected malignant biliary stictures (part 1). Gastrointest Endosc 2002;56:552-561.
15. Heimbach JK, Sanchez W, Rosen CB, Gores GJ. Transperitoneal fine needle aspiration biopsy of hilar cholangiocarcinoma is associated with disease dissemination. HPB (Oxford) 2011;13:356-360.
16. Baron TH, Harewood GC, Rumalla A, et al. A prospective comparison of digital image analysis and routine cytology for the identification of malignancy in biliary tract strictures. Clin Gastroenterol Hepatol 2004;2:214-219. (Pubitemid 38293308)
17. Nichols JC, Gores GJ, LaRusso NF, et al. Diagnostic role of serum CA 19-9 for cholangiocarcinoma in patients with primary sclerosing cholangitis. Mayo Clin Proc 1993;68:874-879. (Pubitemid 23266123)
18. Heimbach JK, Gores GJ, Haddock MG, et al. Predictors of disease recurrence following neoadjuvant chemoreadiotherapy and liver transplantation for unresectable perihilar cholangiocarcinoma. Transplantation 2006;82:1703-1707. (Pubitemid 46035655)
19. Rea DJ, Rosen CB, Nagorney DM, et al. Transplantation for cholangiocarcinoma: when and for whom? Surg Oncol Clin N Am 2009;18:325-337.
20. Gleeson FC, Rajan E, Levy MJ, et al. EUS-guided FNA of regional lymph nodes in patients with unresectable hilar cholangiocarcinoma. Gastrointest Endosc 2008;67:438-433.
21. Moreno Luna LE, Kipp B, Halling KC, et al. Advanced cytologic techniques for the detection of malignant pancreatobiliary strictures. Gastroenterology 2006;131:1064-1072. (Pubitemid 44498705)
22. Murad SD, Ray Kim W, Therneau T, et al. Predictors of pretransplant dropout and post-transplant recurrence in patients with perihilar cholangiocarinoma. Hepatology 2012 Jan 30. http://dx.doi.org/10.1002/hep.25629. [Epub ahead of print].
23. Harewood GC, Baron TH, Stadheim LM, et al. Prospective, blinded assessment of factors influencing the accuracy of biliary cytology interpretation. Am J Gastroenterol 2004;99:1464-1469. (Pubitemid 39180092)
24. Mantel HTJ, Rosen CB, Heimbach JK, et al. Vascular complications after orthotopic liver transplantation after neoadjuvant therapy for hilar cholangiocarcinoma. Liver Transpl 2007;13: 1372-1381. (Pubitemid 47629569)
25. Rea DJ, Heimbach JK, Rosen CB, et al. Liver transplantation with neoadjuvant chemoradiation is more effective than resection for hilar cholangiocarcinoma. Ann Surg 2005;242:451-458 (discussion 458-461).